Genomic solutions for oncology clinical trials
CLIA/CAP-certified sequencing & bioinformatics for pharma, biotech and CRO partners
IntegraGen is a reference genomics partner for oncology clinical trials, with a CLIA/CAP-certified laboratory, advanced bioinformatics and logistics adapted to clinical studies.
We work with academic sponsors, biotechs and CROs on clinical studies, at every stage of the process, with reliability, flexibility and regulatory compliance.
These certifications ensure that IntegraGen meets the highest standards of quality and accuracy in clinical laboratory testing, making the company a trusted partner for companies involved in drug development and clinical trials.
Complete workflow
- Sample logistics
- Organization of pick-ups from investigating centers and logistical traceability.
- Liaison with investigating centers
- Operational support with eTRFs, sample management guides and technical assistance.
- NGS analysis
- Whole Exome Sequencing (WES) - link to each service.
- Whole Genome Sequencing (WGS) - link to each service.
- RNA-seq - link to each service.
- Minimal Residual Disease (MRD) - link to each service.
- All analyses are carried out in our CLIA/CAP-certified laboratory in Évry (France).
- Bioinformatics & Rendering
- Secure rendering.
- Turnaround times (TAT) mapped out and shared with sponsors/CROs.
Our added value
IntegraGen offers specialized sequencing services and clinical experience recognized by leading academic centers:
- Excellence in sequencing since 2009
- Exclusive rights to sequence biological samples.
- Simplified processes / Optimized European logistics
- Reduced risk in sample management, no regulatory constraints in France.
- Network of trust & recommendations
- Leading clinical centers (Gustave Roussy, Institut Pasteur, Bergonié...) recommend IntegraGen.
- CLIA/CAP-certified laboratory
- Validated quality system and access to sponsor audits.
